NIFTY 5023,767.45-0.43%NSE | 24 Jul, 03:31 pm

SENSEX76,059.77-0.43%BSE | 24 Jul, 03:31 pm

NIFTY BANK56,693.50.18%NSE | 24 Jul, 03:31 pm

NIFTY IT28,767.950.82%NSE | 24 Jul, 03:31 pm

S&P 5007,411.980.05%US | 25 Jul, 02:56 am

DOW JONES51,947.250.46%US | 25 Jul, 02:56 am

NASDAQ24,975.82-0.64%US | 25 Jul, 02:45 am

FTSE 10010,736.230.91%UK | 24 Jul, 09:05 pm

NIKKEI 22564,611.15-2.73%JP | 24 Jul, 12:15 pm

HANG SENG24,963.23-0.98%HK | 24 Jul, 01:38 pm

BA

NSE · EQ · EQ

BACIL PHARMA LTD. BACPHAR

NSE:INR 28.224 Jul, 01:06 pm

BSE:INR 28.224 Jul, 01:06 pm

-1.48 · -4.99%

Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

OpenNot available

Previous closeINR 29.68

Day rangeNot available — Not available

52-week rangeNot available — Not available

VolumeNot available

Market capNot available

P/ENot available

IndustryEQ

ISININE711D01018

Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Open full workspace

BACPHARBACIL PHARMA LTD.1d · INR · NSE

Loading validated candles…

Resolution: 1d nativeOHLC validation passed0 candles loadedWheel: zoom · Shift+wheel: pan

Auditable calculations

Daily technical summary

Calculated in the browser from validated historical candles. This is descriptive research, not a buy or sell recommendation.

Calculating technicals…

Company reporting

Financial statements

IND AS · INR crore

Financial statement rows are unavailable.

Fundamentals

Valuation and ratios

Valuation data unavailable.

Risk and consensus

Source-qualified signals

Risk metrics

Risk metrics unavailable.

Recommendations

Recommendations unavailable.

Analyst count, source and as-of date are not provided; target values should be treated as unverified.

Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

Peer data unavailable in the company profile payload.

Shareholding

Ownership

Ownership data is not present in the normalized source.

Corporate actions

Events

Corporate event data unavailable.

Company intelligence

Latest relevant news

Source, timestamp and external destination are shown. Provider relevance scores are not available.

Relevant company news is unavailable.

Company profile

Business information

BACIL PHARMA LTD. market prices and historical candles are loaded from the ShareKeyX Supabase market database.

Industry: Not available
Sector: Not available
Website: Not available
Address: Not available
NSE Code: BACPHAR
BSE Code: Not available

ShareKeyX intelligence

AI analysis

Versioned forecast unavailable on web

This repository contains no authenticated model-inference API, model version, confidence distribution or forecast timestamp. The Android listing is available; verify report availability, entitlement and pricing inside the app.

Open Google Play

Questions

Stock FAQ

What is the symbol and ISIN of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has the symbol BACPHAR and ISIN - INE711D01018.

What is the current price of BACIL PHARMA LTD.?

BACIL PHARMA LTD. is currently trading at NA.

What are the year high and year low of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has a year high of NA and a year low of NA.

What is the market capitalization of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has a market capitalization of NA.

What is the P/E ratio of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has a P/E ratio of NA.

What is the dividend yield of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has a dividend yield of NA.

How is the financial performance of BACIL PHARMA LTD. based on revenue, net income, and EPS?

BACIL PHARMA LTD. has revenue of NA, net income of NA, and EPS of NA.

What is the book value of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has a book value of NA.

What is the debt-to-equity ratio of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has a debt-to-equity ratio of NA.

What are the price-to-book and price-to-sales ratios of BACIL PHARMA LTD.?

BACIL PHARMA LTD. has a price-to-book ratio of NA and a price-to-sales ratio of NA.

Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.